journal article·2019-03

Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics

Liang Chen, Jiulong Zhang, Xiaojun Zhou, Shuguang Yang, Qianqian Zhang, Weizhong Wang, Zhengwei You, Chen Peng, Chuanglong He

Acta Biomaterialia· Volume 86
Publisher page

Abstract

With great potential in nanomedicine, the integration of a metal organic framework (MOF) with a nanocarrier for smart and versatile cancer theranostics still seeks to expand. In this study, MOF was successfully merged with hollow mesoporous organosilica nanoparticles (HMONs) with a polydopamine (PDA) interlayer to form molecularly organic/inorganic hybridized nanocomposites (HMONs-PMOF). The well-defined nanostructure and favorable biocompatibility of HMONs-PMOF were demonstrated first. Doxorubicin hydrochloride (DOX) and indocyanine green (ICG) were separately loaded into the interior cavity of HMONs and the outer porous shell of MOF with high loading efficacy, respectively. The obtained dual drug-loaded nanocomposites (DI@HMONs-PMOF) displayed favorable photothermal properties and pH/NIR-triggered DOX release manner. Furthermore, in vitro cell experiments validated that HMONs-PMOF can efficiently deliver DOX into cancer cells. Upon entry into cancer cells, the photothermal effect of DI@HMONs-PMOF can induce the lysosome rupture, thereby facilitating the "lysosome escape" process and accelerating the DOX diffusion in the cytoplasm. Benefiting from the iron ion coordinated on PDA and ICG confined in MOF, magnetic resonance (MR) and photoacoustic (PA) dual-modality imaging were performed to verify the effective accumulation of DI@HMONs-PMOF at the tumor site. Interestingly, the results also suggested that the existence of ICG can cooperatively enhance the MR imaging capability of prepared nanocomposites. In addition, the significantly improved synergistic therapeutic efficacy was confirmed both in vitro and in vivo. Thus, our results indicated that the merged nanostructure of HMONs and MOF is promising for versatile cancer theranostics. STATEMENT OF SIGNIFICANCE: Metal organic framework (MOF) has recently emerged as a class of fascinating nanocarriers. The integration of MOF with other nanostructures can endow the new nanoformulation with collective functionality and synergistic performance that are not accessed from single-component nanostructure. Herein, we reported the successful merging of MOF and hollow mesoporous organosilica nanoparticles (HMONs) to form a hollow nanocontainer with a well-defined nanostructure. The large cavity of HMONs and highly porous network of MOF enable high drug loading efficacy. Moreover, the dual-modality magnetic resonance and photoacoustic imaging can be realized, which is also benefited from the merged nanostructure. Overall, we expected this paradigm could pave way for integrating MOF with other nanocarriers to achieve more diverse applications.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
2. Cancer nanomedicine: progress, challenges and opportunities10.1038/nrc.2016.108 ↗
3. Recent advances of cocktail chemotherapy by combination drug delivery systems10.1016/j.addr.2015.10.022 ↗
4. Stimuli-responsive nanoparticles for targeting the tumor microenvironment10.1016/j.jconrel.2015.08.050 ↗
5. Nanoscale theranostics for physical stimulus-responsive cancer therapies10.1016/j.biomaterials.2015.09.018 ↗
6. Rethinking cancer nanotheranostics10.1038/natrevmats.2017.24 ↗
7. Recent progress in light-triggered nanotheranostics for cancer treatment10.7150/thno.15217 ↗
8. Nanotechnology for multimodal synergistic cancer therapy10.1021/acs.chemrev.7b00258 ↗
9. NIR-laser-switched in vivo smart nanocapsules for synergic photothermal and chemotherapy of tumors10.1002/adma.201502669 ↗
10. Remotely controlled red blood cell carriers for cancer targeting and near-infrared light-triggered drug release in combined photothermal-chemotherapy10.1002/adfm.201500061 ↗
11. Black phosphorus nanosheet-based drug delivery system for synergistic photodynamic/photothermal/chemotherapy of cancer10.1002/adma.201603864 ↗
12. Multi-responsive photothermal-chemotherapy with drug-loaded melanin-like nanoparticles for synergetic tumor ablation10.1016/j.biomaterials.2015.11.037 ↗
13. Synthesis of Cisplatin(IV) prodrug-tethered CuFeS2 nanoparticles in tumor-targeted chemotherapy and photothermal therapy10.1021/acsami.7b19640 ↗
14. Hyaluronic acid-functionalized gold nanorods with pH/NIR dual responsive drug release for synergetic targeted photothermal chemotherapy of breast cancer10.1021/acsami.7b08700 ↗
15. Tri-stimuli-responsive biodegradable theranostics for mild hyperthermia enhanced chemotherapy10.1016/j.biomaterials.2017.02.025 ↗
16. Multifunctional mesoporous silica nanoparticles with thermal-responsive gatekeeper for NIR light-triggered chemo/photothermal-therapy10.1002/smll.201601137 ↗
17. Graphene quantum dots-capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery magnetic hyperthermia, and photothermal therapy10.1002/smll.201602225 ↗
18. Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy10.1016/j.biomaterials.2016.01.008 ↗
19. Hollow mesoporous organosilica nanoparticles: a generic intelligent framework-hybridization approach for biomedicine10.1021/ja508721y ↗
20. Metalloporphyrin-encapsulated biodegradable nanosystems for highly efficient magnetic resonance imaging-guided sonodynamic cancer therapy10.1021/jacs.6b11846 ↗
21. Glucose-responsive sequential generation of hydrogen peroxide and nitric oxide for synergistic cancer starving-like/gas therapy10.1002/anie.201610682 ↗
22. Biodegradable hollow mesoporous organosilica nanotheranostics for mild hyperthermia-induced bubble-enhanced oxygen-sensitized radiotherapy10.1021/acsnano.7b08103 ↗
23. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging10.1038/nmat2608 ↗
24. Nanoscaled metal-organic frameworks for biosensing, imaging, and cancer therapy10.1002/adhm.201800022 ↗
25. Metal-organic framework (MOF)-based drug/cargo delivery and cancer therapy10.1002/adma.201606134 ↗
26. Imparting functionality to a metal-organic framework material by controlled nanoparticle encapsulation10.1038/nchem.1272 ↗
27. Versatile core-shell nanoparticle@metal-organic framework nanohybrids: exploiting mussel-inspired polydopamine for tailored structural integration10.1021/acsnano.5b01138 ↗
28. Core-shell upconversion nanoparticle@metal-organic framework nanoprobes for luminescent/magnetic dual-mode targeted imaging10.1002/adma.201501779 ↗
29. Porphyrinic metal-organic frameworks coated gold nanorods as a versatile nanoplatform for combined photodynamic/photothermal/chemotherapy of tumor10.1002/adfm.201705451 ↗
30. Construction of homogenous/heterogeneous hollow mesoporous silica nanostructures by silica-etching chemistry: principles, synthesis, and applications10.1021/ar400091e ↗
31. Disulfide-bridged organosilica frameworks: designed, synthesis, redox-triggered biodegradation, and nanobiomedical applications10.1002/adfm.201707325 ↗
32. Validating metal-organic framework nanoparticles for their nanosafety in diverse biomedical applications10.1002/adhm.201600818 ↗
33. Bio-inspired, melanin-like nanoparticles as a highly efficient contrast agent for T1-weighted magnetic resonance imaging10.1021/bm4008138 ↗
34. Indocyanine green-loaded polydopamine-iron ions coordination nanoparticles for photoacoustic/magnetic resonance dual-modal imaging-guided cancer photothermal therapy10.1039/C6NR05502H ↗
35. Polydopamine-based coordination nanocomplex for T1/T2 dual mode magnetic resonance imaging-guided chemo-photothermal synergistic therapy10.1016/j.biomaterials.2015.11.010 ↗
36. Structure-dependent and glutathione-responsive biodegradable dendritic mesoporous organosilica nanoparticles for safe protein delivery10.1021/acs.chemmater.6b03896 ↗
37. Single-step assembly of DOX/ICG loaded lipid-polymer nanoparticles for highly effective chemo-photothermal combination therapy10.1021/nn400334y ↗
38. NIR-activated polydopamine-coated carrier-free “Nanobomb” for In Situ On-demand drug release10.1002/advs.201800155 ↗
39. Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography10.1016/S0039-6257(00)00123-5 ↗
40. Organic molecule-based photothermal agents: an expanding photothermal therapy universe10.1039/C7CS00522A ↗
41. Engineering phototheranostic nanoscale metal-organic frameworks for multimodal imaging-guided cancer therapy10.1021/acsami.6b11579 ↗
42. Core-satellite polydopamine-gadolinium-metallofullerene nanotheranostics for multimodal imaging guided combination cancer therapy10.1002/adma.201701013 ↗
43. pH-Sensitive delivery vehicle based on folic acid-conjugated polydopamine-modified mesoporous silica nanoparticles for targeted cancer therapy10.1021/acsami.7b02457 ↗
44. Efficient RNA delivery by integrin-targeted glutathione responsive polyethyleneimine capped gold nanorods10.1016/j.actbio.2015.05.028 ↗
45. Deoxyribozyme-nanosponges for improved photothermal therapy by overcoming thermoresistance10.1038/s41427-018-0040-7 ↗
46. Multifunctional redox-responsive mesoporous silica nanoparticles for efficient targeting drug delivery and magnetic resonance imaging10.1021/acsami.6b11802 ↗
47. Marriage of albumin-gadolinium complexes and MoS2 nanoflakes as cancer theranostics for dual-modality magnetic resonance/photoacoustic imaging and photothermal therapy10.1021/acsami.7b04488 ↗
48. Redox sensitive hyaluronic acid-decorated graphene oxide for photothermally controlled tumor-cytoplasmselective rapid drug delivery10.1002/adfm.201604620 ↗
49. Gadolinium-loaded Poly(N-vinylcaprolactam) nanogels: synthesis, characterization, and application for enhanced tumor MR imaging10.1021/acsami.6b14219 ↗
50. Mimicking drug-substrate interaction: a smart bioinspired technology for the fabrication of theranostic nanoprobes10.1002/adfm.201603440 ↗
51. Enhanced performance of a molecular photoacoustic imaging agent by encapsulation in mesoporous silicon nanoparticles10.1002/adma.201800512 ↗